Veterinary Dermatology Drugs Market (By Product Type: Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs, Others; By Mode of Administration: Topical, Oral, and Injectable; By Animal Type; By Indication) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

The global veterinary dermatology drugs market size was valued at US$ 3.5 bn in 2020 and is anticipated to hit around US$ 9.8 billion by 2030.

Veterinary dermatology, also referred as pet skin care, involves diagnosis, treatment, and prevention of skin problems in animals. Dermatological disorders or skin disorders are the most common medical conditions seen in animals. The most common sign of a dermatological problem in animals are licking, biting, repeatedly shaking the head, and excessive scratching or chewing of fur and skin. Additional symptoms of skin problems include lumps, hair loss, dandruff, a foul odor from ears or skin, and change in the texture or color of pet's fur or skin. Itching is commonly seen in companion animals; atopic dermatitis is the common cause of itching.

According to a research conducted by the Ferdowsi University of Mashhad Veterinary Teaching Hospital, 20% to 40% of small animals suffered from skin problems in Iran in 2013–2014. Globally, this number may be even higher. Variations in clinical presentations such as the extent of lesions, genetic factors, secondary infections, stage of the disease, and weather conditions could complicate the exact diagnosis of the disease. Atopy is genetically determined predisposition to become allergic to airborne pollens such as grass, weeds, trees, mold, and house dust. In domestic pets such as cats and dogs, atopic dermatitis is the most common cause of biting, chewing, rubbing, or ear infections as well as other chronic infections.

Increase in Medical and Diagnostic Capabilities for Companion Animals to Drive Global Market

The global veterinary dermatology drugs market continues to grow at a rapid pace. The market is driven in developed countries by improved diagnostic and medical capabilities for companion animals. There is a rise in the demand for local anesthetics, anti-inflammatory agents, emollients to treat acne, cleansers, and anti-infectives. Moreover, increase in the demand for veterinary and related products such as dairy and agriculture products and rise in awareness about veterinary dermatology drugs are anticipated to drive the global veterinary dermatology drugs market.

Increase in Ownership of Companion Animals to Fuel Market Growth

Rise in companion animal ownership is a significant trend in the animal healthcare segment. In 2013, around 62% of the U.S. households owned a companion animal (excluding horses) i.e., around 72.9 million homes. Brazil, China, India, Mexico, and Russia are among the top countries with a high growth rate in terms of companion animal ownership.

Report Scope

In terms of product type, the global veterinary dermatology drugs market has been classified into antifungal drugs, antibacterial drugs, antiparasitic drugs, and others. The antibacterial drugs segment dominated the global veterinary dermatology drugs market in 2020, owing to high prevalence of bacterial infection among animals and rise in usage of antibacterial drugs.

Based on mode of administration, the global veterinary dermatology drugs market has been categorized into oral, topical, and injectable. The topical segment captured the largest market share in 2020, as it is among the oldest and most efficient mode of administration of drugs to control inflammatory and immune-mediated skin disorders.

In terms of animal type, the global veterinary dermatology drugs market has been bifurcated into large animals and small animals. The large animals segment has been split into equine, bovine, and others. The small animals segment has been segregated into cats, dogs, and others.

Based on indication, the global veterinary dermatology drugs market has been divided into infectious diseases, skin cancer, autoimmune skin diseases, parasitic infections, and others. The infectious diseases segment accounted for significant share of the market in 2020, as infectious diseases are the most common type of veterinary dermatology conditions in companion as well as livestock animals.

In terms of region, North America is projected to be a highly attractive market for veterinary dermatology drugs from 2021 to 2031. High revenue from the region can be attributed to increase in government and private funding and large volume of tests performed. North America is also home to several key players such as Idexx, VCA, and Thermo Fisher, which further propels the market.

The veterinary dermatology drugs market in Asia Pacific is expected to be driven by high adoption of veterinary dermatology drugs, vaccines, and medicated feed additives for the well-being of the rapidly increasing livestock animal population in the region

Key players operating in the global veterinary dermatology drugs market are

• • Merial, Zoetis, Inc.
  • Ceva Sante Animale
  • Vetmedica
  • IDEXX Laboratories
  • Vetoquinol S.A.
  • Virbac S.A.
  • Bayer Animal Health
  • Boehringer Ingelheim
  • Elanco
  • Novartis Animal Health
  • SAVAVET
  • Toray Industries
  • AB Science

This report focuses on veterinary dermatology drugs market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall veterinary dermatology drugs market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global veterinary dermatology drugs market.

The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.

In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Major Key Points Covered in Report:

Executive Summary: It includes key trends of the veterinary dermatology drugs market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the veterinary dermatology drugs market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Veterinary dermatology drugs market.

Market Segments: This part of the report discusses about product, application and other segments of the veterinary dermatology drugs market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses about the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

Regional Analysis

The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.

The report provides in-depth segment analysis of the global veterinary dermatology drugs market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the veterinary dermatology drugs market.

The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.

Competitive Landscape and Market Share Analysis

The veterinary dermatology drugs market competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, veterinary dermatology drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2017-2020, this study provides the veterinary dermatology drugs sales, revenue and market share for each player covered in this report.

• Crucial data regarding the major contenders, product portfolio, market remuneration, and production patterns are documented in the report.
• The report presents the pricing models followed by each company, alongside the gross margins and market share held by each company.

Research Methodology

The research methodology adopted by analysts for compiling the global veterinary dermatology drugs market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global veterinary dermatology drugs market.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2021) and forecast (2021-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.